Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics

Table of Contents

1 EXECUTIVE SUMMARY

• Scope and Methodology
  • Scope and Segmentation
  • Methodology
• Technology Snapshot
  • The Concept of Microfluidics
  • Lab-on-a-Chip Technology
  • Key Findings

2 TECHNOLOGY ANALYSIS

• Technology Primer
  • Related Definitions
  • Importance of Lab Automation Robotics and Miniaturization
  • Microfluidics and LOC Technologies and Their Advantages
  • Technology Applications
• Technology Trends
  • Trends in Drug Discovery--Screening More Compounds in Less Time
  • Trends in Clinical Diagnostics--Genomics and Proteomics
  • Future Trends and Technology Impact
• Noteworthy Developments in Corporate and Academic sectors
  • Corporate Sector
  • Universities and Academic Institutions

3 TECHNOLOGY ADOPTION FACTOR ANALYSIS

• Influential Market Factors
  • Technology Accelerators
  • Technology Barriers
  • SWOT Analysis
  • Strategic Recommendations
• Other Factors
  • Funding Analysis
  • Mergers and Acquisitions/Collaborations and Partnerships
  • Technology Licensing and Technology Transfer Opportunities

4 ASSESSMENT OF TECHNOLOGY INNOVATION IN COMPANIES AND UNIVERSITIES

• Technology Innovations in Companies--North America
  • Microfluidic Instruments for Drug Discovery and Diagnostics--USA
  • Chip-Based Protein Crystallization Technology Aids in Drug Discovery--USA
  • Semiconductor-Based Photonic LOC Solutions for Biomedical Applications--USA
  • Digital Microfluidics--A Breakthrough Solution for Automated Nanoliter Fluid Handling--USA
  • Microfluidic Chip-Based Systems for Liquid Chromatography and Mass Spectrometry--USA
  • A Simple-to-Use High-Throughput Nanofluidic Technology for SNP Genotyping--USA
  • Microfluidic Devices for Lifesciences Applications--Canada
  • Credit Card-Like Microfluidic Devices for Multiple Applications--USA
  • POC Testing through Credit Card-Sized Microfluidic Devices--Canada
  • A Pioneer Chip-Based AIDS Diagnostic Device for Resource-Poor Settings--USA
• Technology Innovations in Companies--Europe and APAC
  • Microfluidics Systems for Drug Discovery and Cellular Diagnostics--Ireland
  • Microchip for Automated Sample Preparation and Manipulation of Biological Samples--Switzerland
  • Microfluidics Solutions for Lifesciences Applications-UK
  • An All-in-One Chip-Based Gene Analysis System--Germany
  • Microfluidics Systems for Drug Discovery and Lead Optimization--Netherlands
  • Reverse Transcriptase PCR Takes Place on an LOC Platform--Germany
  • Microfluidic Instruments for Chemistry Processes for Drug Discovery Research--Hungary
  • Microfluidic Chip-Based Platforms for Lifesciences Applications--Germany
  • Microfluidic Device with Reduced Potency Data-Receiving Time--UK
  • Instant ELISA Kit Using LOC Technology--Switzerland
  • Protein Quantification Using a Lab on a Compact Disk-Sweden
  • DNA Biochip Assay for Diagnosing Sepsis and Other Infectious Diseases--Finland
  • A Handheld Microfluidic Diagnostic System for Universal Applications--Australia
• Technology Innovations in Universities and Academia
  • A First of Its Kind High-Resolution Microscope on a Chip--USA
  • Nanopumps that Have Achieved Phenomenal Flow Rates May Pave Way for Portable LOC--USA
  • Toward the Development of an LOC for an Array of Applications--Canada
  • A Microfluidic Liquid Chromatography System for Proteomic Investigations--USA
  • A Novel Microfluidic Heating System for Rapid Continuous Flow PCR-on-a-Chip--USA
  • A Fully Integrated System for Genetic Profiling--EU
  • Switching on UV Unclogs Microfluidic Nanopipes--USA
  • Thermal Fluid Actuation System for LOC Applications--Sweden
  • Microfluidic Crystallization Platform Yields Quick Crystals--USA

5 IMPORTANT PATENTS AND KEY PARTICIPANTS

• Patents
  • Corporate Patents
  • Academic Patents
• Key Industry Participants
  • Corporate Contacts
  • Academic Contacts

6 DECISION SUPPORT DATABASE

• Database Tables
  • Number of Biotech Companies (2002-2012)
  • Government R&D Investment in Biotechnology (2002-2012)
  • Venture Capital Investment in Biotechnology (2002-2012)
  • Pharmaceuticals R&D Expenditure (2002-2012)
  • Incidence of Prostate Cancer (2002-2012)
  • Incidence of Breast Cancer (2002-2012)